Junshi Biosciences Announces European Commission Approval for Marketing of Toripalimab
Junshi Biosciences SHANGHAI, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical compa...